Pelthos Therapeutics's three largest insider shareholders as of August 04, 2026 are Todd C Davis (Director, 1.50Mn shares), Pharmaceuticals Inc Ligand (TenPercentOwner, 1.50Mn shares), Ezra M Friedberg (Director, 82.03K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Pharmaceuticals Inc Ligand | - | 1,500,000 | 0 | 02 Jul, 2025 |
| Peter Greenleaf | - | 24,681 | 0 | 06 Apr, 2026 |
| Todd C Davis | - | 0 | 1,500,000 | 03 Jul, 2025 |
| Knuettel Ii Francis | Chief Financial Officer | 0 | 10,000 | 03 Jul, 2025 |
| Andrew J. Einhorn | - | 12,000 | 0 | 29 Dec, 2025 |
| Matthew Pauls | - | 15,150 | 0 | 06 Apr, 2026 |
| Ezra M Friedberg | - | 82,027 | 0 | 06 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Apr, 2026 | Peter Greenleaf | Common Stock | D | 420 | $20.52 | 25,058 | D | S |
| 02 Apr, 2026 | Matthew Pauls | Common Stock | D | 415 | $20.52 | 15,521 | D | S |
| 02 Apr, 2026 | Ezra M Friedberg | Common Stock | D | 293 | $20.51 | 82,292 | D | S |
| 02 Apr, 2026 | Matthew Pauls | Common Stock | D | 371 | $21.36 | 15,150 | D | S |
| 02 Apr, 2026 | Peter Greenleaf | Common Stock | D | 377 | $21.36 | 24,681 | D | S |
| 02 Apr, 2026 | Ezra M Friedberg | Common Stock | D | 265 | $21.36 | 82,027 | D | S |
| 23 Dec, 2025 | Andrew J. Einhorn | Common Stock | A | 12,000 | - | 12,000 | D | A |
| 02 Jul, 2025 | Matthew Pauls | Common Stock | A | 8,493 | $0.00 | 8,493 | D | M |
| 02 Oct, 2025 | Matthew Pauls | Common Stock | A | 2,123 | $0.00 | 10,616 | D | M |
| 10 Dec, 2025 | Matthew Pauls | Common Stock | D | 9,542 | $0.00 | 1,074 | D | G |
| 02 Jul, 2025 | Matthew Pauls | Restricted Stock Units | D | 8,493 | $0.00 | 16,985 | D | M |
| 02 Oct, 2025 | Matthew Pauls | Restricted Stock Units | D | 2,123 | $0.00 | 14,862 | D | M |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 5,999 | $28.00 | 34,001 | I | S |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 2,000 | $28.14 | 32,001 | I | S |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 1 | $28.50 | 32,000 | I | S |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 2,000 | $28.01 | 30,000 | I | S |
| 02 Jul, 2025 | Scott M. Plesha | Restricted Stock Units | A | 83,678 | - | 83,678 | D | A |
| 02 Jul, 2025 | Scott M. Plesha | Restricted Stock Units | A | 83,678 | - | 83,678 | D | A |
| 02 Jul, 2025 | Scott M. Plesha | Restricted Stock Units | A | 83,678 | - | 83,678 | D | A |
| 02 Jul, 2025 | Scott M. Plesha | Restricted Stock Units | A | 83,678 | - | 83,678 | D | A |